Company intelligence

MRVI

Maravai LifeSciences Holdings, Inc. · NASDAQ · Healthcare

Price$8.52+7.85% · +$0.62

Market cap2.35BEquity value

P / E-44.8Trailing ratio

Volume2.63MLatest session

Market data

MRVI price chart

TradingView

Related signals

1 min delayed

Browse public MRVI signals with their source context and measured market impact. Open any signal for its permanent analysis page.

MRVIMay 13, 2025-2.70% since signal

These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results

MRVI reported losses of 8 cents per share, missing estimates. Quarterly sales reached $46.85 million, exceeding expectations of $44.01 million. Projected FY2025 sales range is $185M to $205M, slightly below estimates. Analysts adjusted price targets; one maintained Buy but lowered it. Shares fell 3.5% post-announcement, indicating market reaction.

View signal analysis

Research